Amkor Technology, Inc. (AMKR) Stands Out Among Market Cap Peers

Page 2 of 2

Seeing as Amkor Technology, Inc. (NASDAQ:AMKR) has witnessed declining sentiment from hedge fund managers, we can see that there was a specific group of hedge funds that decided to sell off their entire stakes by the end of the third quarter. At the top of the heap, Israel Englander’s Millennium Management cut the biggest investment of the 700 funds watched by Insider Monkey, valued at close to $5.6 million in stock. Neil Chriss’ fund, Hutchin Hill Capital, also sold off its stock, about $1.3 million worth. These transactions are interesting, as aggregate hedge fund interest dropped by 2 funds by the end of the third quarter.

Let’s now take a look at hedge fund activity in other stocks – not necessarily in the same industry as Amkor Technology, Inc. (NASDAQ:AMKR) but similarly valued. These stocks are Opus Bank (NASDAQ:OPB), Envestnet Inc (NYSE:ENV), Seacor Holdings, Inc. (NYSE:CKH), and Aimmune Therapeutics Inc (NASDAQ:AIMT). All of these stocks’ market caps match Amkor Technology, Inc.’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
OPB 13 559613 2
ENV 13 45953 -5
CKH 12 212616 -3
AIMT 10 190657 10

As you can see these stocks had an average of 12 hedge funds with bullish positions and the average amount invested in these stocks was $252 million. That figure was $56 million in Amkor Technology, Inc.’s case. Opus Bank (NASDAQ:OPB) is the most popular stock in this table. On the other hand Aimmune Therapeutics Inc (NASDAQ:AIMT) is the least popular one with only 10 bullish hedge fund positions. Compared to these stocks Amkor Technology, Inc. (NASDAQ:AMKR) is more popular among hedge funds, although the amount of capital invested in it is quite low. Nonetheless, considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Page 2 of 2